Danny L. Dearen - Feb 25, 2022 Form 4 Insider Report for Axonics, Inc. (AXNX)

Role
Officer
Signature
/s/ Danny L. Dearen
Stock symbol
AXNX
Transactions as of
Feb 25, 2022
Transactions value $
-$353,424
Form type
4
Date filed
3/1/2022, 07:13 PM
Previous filing
Oct 3, 2023
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXNX Common Stock Options Exercise $166K +6.42K +22.74% $25.82 34.7K Feb 25, 2022 Direct
transaction AXNX Common Stock Options Exercise $50.8K +3.58K +10.33% $14.19* 38.2K Feb 25, 2022 Direct
transaction AXNX Common Stock Sale -$570K -10K -26.15% $57.00 28.2K Feb 25, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXNX Stock Options (Right to buy) Options Exercise $0 -6.42K -30.44% $0.00 14.7K Feb 25, 2022 Common Stock 6.42K $25.82 Direct F2
transaction AXNX Stock Options (Right to buy) Options Exercise $0 -3.58K -34.93% $0.00 6.67K Feb 25, 2022 Common Stock 3.58K $14.19 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2 The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on December 12, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on December 1, 2023, provided the reporting person remains in continuous service on each vesting date.
F3 The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 1, 2023, provided the reporting person remains in continuous service on each vesting date.